Keeping an Eye on Teva- Pharmaceutical Industries Ltd. ADR (TEVA) After Insider Trading Activity

Samantha Gray

In a filing, Teva- Pharmaceutical Industries Ltd. ADR revealed its Officer Fox Christine acquired Company’s shares for reported $0.75 million on Nov 14 ’25. In the deal valued at $25.11 per share,30,000 shares were bought.

Then, MIGNONE ROBERTO sold 200,000 shares, generating $4,821,880 in total proceeds. Upon selling the shares at $24.11, the Director now owns 495,000 shares.

Before that, Weiss Amir sold 12,300 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $300,564 were divested by the Chief Accounting Officer at a price of $24.44 per share. As a result of the transaction, Weiss Amir now holds 17,950 shares, worth roughly $0.46 million.

Goldman initiated its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy in a research note published on June 06, 2025; the price target was $24. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late May with a ‘”a Buy”‘ rating. JP Morgan also remained covering TEVA and has increased its forecast on May 12, 2025 with a “an Overweight” recommendation from previously “Neutral” rating. Argus revised its rating on July 10, 2024. It rated TEVA as “a Buy” which previously was an “a Hold”.

Price Performance Review of TEVA

On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -0.51% to $25.41. Over the last five days, the stock has gained 6.01%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 48.51% since the year began. Nevertheless, the stocks have risen 15.29% over the past one year. While a 52-week high of $26.38 was reached on 11/13/25, a 52-week low of $12.47 was recorded on 04/10/25.

Levels Of Support And Resistance For TEVA Stock

The 24-hour chart illustrates a support level at 24.98, which if violated will result in even more drops to 24.56. On the upside, there is a resistance level at 25.75. A further resistance level may holdings at 26.10.

How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?

A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2025-10-31, growing by 0.51 million shares to a total of 50.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 49.88 million shares. There was a rise of 1.02%, which implies that there is a positive sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.